RETINA NEWS SPOTLIGHT
Breaking barriers: Australian Society of Ophthalmologists’ first woman CEO steps up
The Australian Society of Ophthalmologists (ASO) marked a milestone last month with the appointment of Katrina Ronne as its first woman chief executive officer (CEO) in the organization’s 43-year history. Ronne aims to lead with a culture of inclusivity and advocacy for equitable eye care access…
Continue Reading Breaking barriers: Australian Society of Ophthalmologists’ first woman CEO steps up
Large language model-generated summaries improve interdisciplinary communication in ophthalmology
The results of a large randomized, quality improvement study in the US suggested that integrating large language model (LLM)-generated plain language summaries into ophthalmology notes can improve interdisciplinary communication, although ongoing review and safety monitoring are necessary for successful clinical implementation,1 according to the first author,…
Early-onset atopic dermatitis linked to higher risk of pediatric uveitis
Taiwanese investigators found in their cohort study that children with early-onset atopic dermatitis had an increased risk of developing uveitis and should be carefully observed to identify that onset.1 The study was led by Yung-Yu Chu, MD, from the Department of Ophthalmology, Chi Mei Medical Center,…
Continue Reading Early-onset atopic dermatitis linked to higher risk of pediatric uveitis
Cell-based subretinal implant may partially restore vision in geographic atrophy
April 07, 2025 3 min read Key takeaways: Retinal implants have a history of challenges, and questions remain about their utility. A bioengineered RPE stem cell-derived retinal implant has shown ability to partially restore vision in geographic atrophy. SEVILLE, Spain — A cell-based subretinal implant
Continue Reading Cell-based subretinal implant may partially restore vision in geographic atrophy
Alumis and Acelyrin file a definitive proxy statement for proposed merger
Alumis and Acelyrin have filed a definitive proxy statement/prospectus with the US Securities and Exchange Commission for the proposed merger of the companies.According to a joint statement from the company, each company will hold a respective special meeting of stockholders on Tuesday, May 13, 2025. Stockholders…
Continue Reading Alumis and Acelyrin file a definitive proxy statement for proposed merger
Nordic Pharma receives CE Mark for canalicular gel Lacrifill
In a press release, Nordic Pharma, a subsidiary of Nordic Group B.V., announced that its canalicular gel Lacrifill has received CE Mark approval in the European Union. The approval arrived several months ahead of schedule, Nordic Pharma noted. Lacrifill is a cross-linked hyaluronic acid gel designed…
Continue Reading Nordic Pharma receives CE Mark for canalicular gel Lacrifill
Explore
Early-onset atopic dermatitis linked to higher risk of pediatric uveitis
Taiwanese investigators found in their cohort study that children with early-onset atopic dermatitis had an increased risk of developing uveitis and should…
Continue Reading Early-onset atopic dermatitis linked to higher risk of pediatric uveitis
Cell-based subretinal implant may partially restore vision in geographic atrophy
April 07, 2025 3 min read Key takeaways: Retinal implants have a history of challenges, and questions remain about their utility. A bioengineered RPE stem cell-derived retinal implant has shown ability to partially restore vision in geographic atrophy. SEVILLE, Spain — A cell-based subretinal implant
Continue Reading Cell-based subretinal implant may partially restore vision in geographic atrophy
Alumis and Acelyrin file a definitive proxy statement for proposed merger
Alumis and Acelyrin have filed a definitive proxy statement/prospectus with the US Securities and Exchange Commission for the proposed merger of the…
Continue Reading Alumis and Acelyrin file a definitive proxy statement for proposed merger